TENAX THERAPEUTICS, INC. — Cash Flow Charts
41 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-34.9% -$2M
$-7M
Free Cash Flow↓-34.9% -$2M
$-7M
Investing Cash Flow
$0
Financing Cash Flow↑+17229.9% +$12M
$12M
Capex
$2K
Stock-Based Comp↑+393.8% +$4M
$5M
Debt Repaid
$0
D&A↓-100.0% -$5K
$0
SBC Allocated Expense↑+397.4% +$4M
$5M
SBC Unrecognized Cost
$15M